Molecular Bases of Serotonin Reuptake Inhibitor Antidepressant-Attributed Effects in COVID-19: A New Insight on the Role of Bradykinins

Widely available effective drugs to treat coronavirus disease-2019 (COVID-19) are still limited. Various studies suggested the potential contribution of selective serotonin-reuptake inhibitor (SSRI) antidepressants to alleviate the clinical course of COVID-19. Initially, SSRI antidepressant-attribut...

Descripción completa

Detalles Bibliográficos
Autores principales: Gouda, Ahmed S., Mégarbane, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502697/
https://www.ncbi.nlm.nih.gov/pubmed/36143272
http://dx.doi.org/10.3390/jpm12091487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502697/
https://www.ncbi.nlm.nih.gov/pubmed/36143272
http://dx.doi.org/10.3390/jpm12091487

Ejemplares similares